New drug combo aims to shrink sinus tumors, save eyes and face
NCT ID NCT00707473
Summary
This study is testing a three-drug chemotherapy combination for people with advanced cancers in the nasal cavity or sinuses who haven't had treatment yet. The goal is to see if these drugs can shrink the tumors enough to improve the success of follow-up radiation or surgery, and to help preserve nearby organs like the eyes. Researchers will track how well the treatment works and its side effects over several years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SINONASAL UNDIFFERENTIATED CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.